Skip to content

Meet us at COP31Read more

Onco-Innovations Ltd Sustainability Reports

Onco-Innovations Limited is a pre-clinical stage biotechnology company that develops drug candidates for cancer treatments. The company focuses on advancing next-generation DNA Damage Response (DDR) therapies, specifically developing Polynucleotide Kinase Phosphatase (PNKP) inhibitors such as its lead candidate ONC010.

Sector: Manufacturing

Country: Canada

Exchange: Cboe Canada

LEI: 529900BRM2J6NM6CYX21

1 reports from 2025 to 2025